CYRX
Cryoport, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 12 to Mar 23 ▼ 3 days of insider sells: $471.3K by 4 insiders, avg $7.86
- Jun 4 to Jun 11 ▼ 4 days of insider sells: $3.6M by 3 insiders, avg $15.92
- Aug 11 ▼ 1 insider sell $429.4K at $14.91
- Oct 30 ▼ Short interest jumps 37.3% to 3.48M
- Nov 5 ▲ Cryoport reported Q3 2026 revenue of $50.4 million, up 13% year-over…
- Nov 5 ▼ Earnings: CYRX Q3 2026 Earnings: EPS $-0.25 (-39.0% vs est)
- Nov 9 to Nov 10 ▼ 2 days of insider sells: $1.7M by 2 insiders, avg $20.17
Signal stack
Where each data set points today.
- InsidersBEARISH
6 insiders sold $6.2M.
- InstitutionsMIXED
Q3 2026: 20 added (0 new), 15 trimmed or exited.
- AnalystsBULLISH
13 of 15 rate it Buy or better. Median target $21.00 (+6%).
- EstimatesRISING
Current-quarter EPS estimate −$0.155 → −$0.147 over 90 days.
- Short sellersBUILDING
Short interest +37.3% to 3.48M shares. 4.1 days to cover, ≈6.9% of shares.
- TrendUPTREND
13% above its 50-day average. New closing high $20.74 on Nov 10.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| Qube Research & Technologies Ltd | DOUBLED | $13.3M |
| UBS Group AG | TRIM | $8.5M |
| PANAGORA ASSET MANAGEMENT INC | ADD | $8.1M |
| Russell Investments Group, Ltd. | DOUBLED | $6.9M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $2.4M |
| JANE STREET GROUP, LLC | TRIM | $2.4M |
| SEI INVESTMENTS CO | ADD | $1.3M |
| FRANKLIN TEMPLETON INC | TRIM | $1.1M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
15 analystsPrice is inside the target range. Median implies +6%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 6, 2026 | Keybanc MAINTAIN | Overweight |
| Nov 6, 2026 | Needham MAINTAIN | Buy |
| Oct 13, 2026 | BTIG MAINTAIN | Buy |
| Oct 1, 2026 | Guggenheim MAINTAIN | Buy |
| Sep 18, 2026 | BTIG REITERATE | Buy |
| Aug 7, 2026 | Guggenheim MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Sawicki Mark W Chief Scientific Officer Nov 10, 2026 | SELL | $199.3K |
HANCOCK DANIEL M Director Nov 9, 2026 | EXERCISE | $291.9K |
HANCOCK DANIEL M Director Nov 9, 2026 | EXERCISE | $301.4K |
HANCOCK DANIEL M Director Nov 9, 2026 | EXERCISE | $143.8K |
HANCOCK DANIEL M Director Nov 9, 2026 | SELL | $1.5M |
SHELTON JERRELL President, CEO Aug 11, 2026 | SELL | $429.4K |
ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 11, 2026 | EXERCISE | $161.3K |
ZECCHINI EDWARD J Chief Digital and Tech Officer Jun 11, 2026 | SELL | $486.2K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | -$0.15 | -$0.17–-$0.13 | +5.4% | $51.1M |
| Next Q | -$0.17 | -$0.20–-$0.13 | +3.8% | $52.7M |
| Current FY | -$0.77 | -$0.88–-$0.70 | -6.6% | $198.1M |
| Next FY | -$0.52 | -$0.62–-$0.45 | +10.2% | $218.1M |
Short side
FINRA· Oct 30, 2026SecBot reports
10 filings · 2 bullish · 0 bearish · 1 mixed · 7 neutral- NEUTRAL CLUSTERNov 12, 2026
Two Cryoport insiders sold shares totaling $1.70M in the week after Q3 earnings beat and raised…
The Hancock sale was pre-planned under 10b5-1 and likely unrelated to the positive earnings surprise. Sawicki's unplanned sale is small relative to market cap and may reflect personal liquidity…
- NEUTRAL 144Nov 10, 2026
Mark W. Sawicki, an officer of Cryoport, filed a Form 144 notice of intent to sell 10,000 shares…
The proposed sale is small relative to market cap and appears to be a routine diversification move by an officer. Monitor for the actual sale on Form 4; the filing itself does not indicate insider…
- NEUTRAL 144Nov 9, 2026
Director Daniel M. Hancock filed a Form 144 notice of intent to sell 74,379 shares of Cryoport…
The filing is a routine advance notice of a director's intent to sell shares acquired via option exercise. No additional context (e.g., lock-up expiry, earnings date) is provided. Monitor for the…
- BULLISH 8-KNov 5, 2026
Cryoport reported Q3 2026 revenue of $50.4 million, up 13% year-over-year, and a GAAP net loss per…
The raised guidance and continued improvement in adjusted EBITDA suggest Cryoport is on a path to profitability. Monitor the Q4 2026 launch of the Santa Ana Global Supply Chain Center and any…
All CYRX filing & press-release reports (10)
- CLUSTER reportNov 12, 2026
- 144 reportNov 10, 2026
- 144 reportNov 9, 2026
- 8-K reportNov 5, 2026
- PRESS-RELEASE reportOct 22, 2026
- INST-CLUSTER reportAug 14, 2026
- INST-CLUSTER reportJun 21, 2026
- CLUSTER reportJun 12, 2026
- CLUSTER reportMar 16, 2026
- CLUSTER reportMar 16, 2026